Gastric pentadecapeptide Bpc 157, a new staple peptide in clinical phase II for inflammatory bowel disease (Pliva, PL-14736) as therapy for HSV-1 and Hsv-2 infection | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

7557999

Reference Type

Journal Article

Title

Gastric pentadecapeptide Bpc 157, a new staple peptide in clinical phase II for inflammatory bowel disease (Pliva, PL-14736) as therapy for HSV-1 and Hsv-2 infection

Author(s)

Turkovic, B; Sikiric, P; Serwerth, S; Rucman, R; Petek, M; Anic, T

Year

2003

Is Peer Reviewed?

Yes

Journal

Gastroenterology
ISSN: 0016-5085
EISSN: 1528-0012

Publisher

Elsevier

Volume

124

Issue

Page Numbers

A560-A560

DOI

10.1016/s0016-5085(03)82835-4

Web of Science Id

WOS:000182675902831

URL

http://://WOS:000182675902831
Exit